Woburn

Over $90,000 Donated to the Boys & Girls Clubs of America and the Warrior For Life Fund in honor of late Woburn resident, Dan White

Retrieved on: 
Wednesday, September 27, 2023
Organization, HPI, L.A. Care Health Plan, Boy, News, Boys & Girls Clubs of America, Woburn, Toy

WESTBOROUGH, Mass., Sept. 27, 2023 /PRNewswire-PRWeb/ -- Health Plans, Inc. (HPI) is happy to share exciting news from its president and CEO, Deb Hodges—a lifelong Woburn resident.

Key Points: 
  • All proceeds from the tournament went directly to the Boys & Girls Clubs of America and the Warrior For Life Fund.
  • HPI raised over $90,000 at its third annual Daniel White Memorial Golf Tournament at the Pinehills Golf Club in beautiful Plymouth, Massachusetts.
  • All proceeds from the tournament went directly to the Boys & Girls Clubs of America and the Warrior For Life Fund.
  • This event honors Dan White, a Woburn resident, Woburn Boys & Girls Club supporter, and beloved colleague of more than 24 years, who passed away in 2020.

Major Legal Association Summons Hawksearch to Power their Revenue Strategy with Unbound

Retrieved on: 
Thursday, December 9, 2021
Unbound, NASDAQ, GLOBE, CEO, E-commerce, Online shopping

Bridgeline added Hawksearch to their portfolio this year to drive more value for their Unbound customers.

Key Points: 
  • Bridgeline added Hawksearch to their portfolio this year to drive more value for their Unbound customers.
  • The internationally recognized legal association, a premier customer that has used Unbound to drive revenue for more than 5 years, has decided to extend their Unbound integration with Hawksearch for its ability to organize content, faceted navigation, and AI-powered relevant recommendations.
  • Unbound, an original Bridgeline product, is an ideal platform for franchise, eCommerce, and large-scale corporations to enhance user experience and boost revenue.
  • We are excited to see such great demand from our Unbound customers for Hawksearch.

Biofrontera Inc. Announces Notice of Allowance for U.S. Method-of-Use Patent on PDT-lamp

Retrieved on: 
Wednesday, December 8, 2021
USPTO, Company, Dermatology, Patent, Health, GLOBE, SEC, Patient safety, Face, LED, Private Securities Litigation Reform Act, Scalp, BFRI, Skin, PDT, United States Patent and Trademark Office, DUSA Pharmaceuticals, COVID-19, Intellectual property, FDA, Marketing, Nasdaq, XL, Impetigo, Pharmaceutical industry

This is a patent covered by the exclusive license of Biofrontera Inc. to sell Ameluz and the RhodoLED lamp series in the USA.

Key Points: 
  • This is a patent covered by the exclusive license of Biofrontera Inc. to sell Ameluz and the RhodoLED lamp series in the USA.
  • The technical improvements claimed in the patent allow for greater standardization and procedural compliance for photodynamic therapy (PDT) with the combination product.
  • The 785 patent describes specific features of the LED arrays of the five panels constituting the lamp head of RhodoLED XL.
  • The 785 patent constitutes a continuation-in-part of U.S. patent number 17/071,496, and thus claims the same priority date of October 15, 2020.

German Sports Retailer Steps Up Their Game with Bridgeline’s NLP Site Search

Retrieved on: 
Tuesday, December 7, 2021
NLP, SKU, NASDAQ, GLOBE, Artificial intelligence, Technology, Sport, Natural language, Natural language processing, Online shopping

WOBURN, Mass., Dec. 07, 2021 (GLOBE NEWSWIRE) -- Bridgeline Digital, Inc. (NASDAQ: BLIN), a cloud-based marketing technology software provider, announced today that their site search product has been chosen by a German sports apparel business to support their lead augmentation software.

Key Points: 
  • WOBURN, Mass., Dec. 07, 2021 (GLOBE NEWSWIRE) -- Bridgeline Digital, Inc. (NASDAQ: BLIN), a cloud-based marketing technology software provider, announced today that their site search product has been chosen by a German sports apparel business to support their lead augmentation software.
  • The German company, one of the first online sports outfit stores, chose Bridgelines product after recognizing the added value of Natural Language Processing (NLP) in site search.
  • The online sports retailer decided to integrate with Bridgelines advanced site search technology that offers NLP.
  • The site searchs advanced Artificial Intelligence algorithm is ideal for high SKU-count catalogs in languages across the globe.

Nearly half of security events handled by Kaspersky’s incident response team in 2021 were connected to ransomware

Retrieved on: 
Tuesday, December 7, 2021
Story of the Year, Internet, GLOBE, Business, Threat intelligence, TTP/A, VPN, Efficiency, Pressure, DarkSide, REvil, Organization, RDP, GERT, Network Lateral Movement, Linux, Government, Response, Intelligence, Goal, Solution, Acquisition, Ransomware, Risk management, Cryptocurrency, Medical imaging

Woburn, MA, Dec. 07, 2021 (GLOBE NEWSWIRE) -- Today Kaspersky revealed that nearly half of security incidents handled by its Global Emergency Response Team (GERT) from January to November 2021 were connected to ransomware, an increase of nearly 9% from 2020.

Key Points: 
  • Woburn, MA, Dec. 07, 2021 (GLOBE NEWSWIRE) -- Today Kaspersky revealed that nearly half of security incidents handled by its Global Emergency Response Team (GERT) from January to November 2021 were connected to ransomware, an increase of nearly 9% from 2020.
  • Kasperskys Global Emergency Response Team is called in by companies after a security breach to limit the damage and prevent an attack from spreading.
  • This is known as incident response (IR) and is reserved for mid-sized to large organizations.
  • Together, attacks against those two industries accounted for nearly 50% of all ransomware-related IR requests in 2021.

Biofrontera Inc. Enrolls First Subject in Phase 1 Safety Study Evaluating Photodynamic Therapy with Three Tubes of Ameluz®

Retrieved on: 
Monday, December 6, 2021
News, Trial of the century, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Safety, BFRI, PK, Private Securities Litigation Reform Act, Face, Company, SEC, DUSA Pharmaceuticals, Scalp, COVID-19, Dermatology, Nasdaq, GLOBE, Health, Impetigo, Marketing, PDT, FDA, XL, Food, Standard of care, Pharmaceutical industry

This open-label study is being conducted at eight sites and will enroll 100 subjects with mild-to-severe AK on the face and scalp.

Key Points: 
  • This open-label study is being conducted at eight sites and will enroll 100 subjects with mild-to-severe AK on the face and scalp.
  • The Phase 1 study follows a maximal-usage pharmacokinetics (PK) clinical study that was completed in early 2021.
  • As announced in June, results from that PK study were presented to the U.S. Food and Drug Administration (FDA).
  • With a focus on the fields of photodynamic therapy (PDT) and topical antibiotics, Biofrontera currently commercializes the FDA-approved flagship drug Ameluz in the United States.

Yield10 Bioscience to Participate in the Benzinga Global Small Cap Conference on December 9, 2021

Retrieved on: 
Monday, December 6, 2021
Conference, Company, Yield10 Bioscience, Agriculture, Goal, Nasdaq, Twitter, GLOBE, PHA, LinkedIn, Doctor of Philosophy, Facebook

WOBURN, Mass., Dec. 06, 2021 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN), an agricultural bioscience company, announced today that management will participate at the Benzinga Global Small Cap Conference on December 9, 2021.

Key Points: 
  • WOBURN, Mass., Dec. 06, 2021 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN), an agricultural bioscience company, announced today that management will participate at the Benzinga Global Small Cap Conference on December 9, 2021.
  • President and Chief Executive Officer Oliver Peoples, Ph.D. will deliver his presentation at 10:30 AM EST on Thursday, December 9, 2021.
  • Peoples will also be available to participate in one-on-one meetings with investors who are registered to attend the conference.
  • For more information about the company, please visit www.yield10bio.com , or follow the Company on Twitter , Facebook and LinkedIn .

Biofrontera Inc. Announces Notice of Allowance for U.S. Patent on Innovative Illumination Protocol

Retrieved on: 
Thursday, December 2, 2021
Patent, Photodynamic therapy, BFRI, Private Securities Litigation Reform Act, Face, Company, United States Patent and Trademark Office, LSA, SEC, DUSA Pharmaceuticals, Scalp, COVID-19, Nociception, Dermatology, BF, Nasdaq, GLOBE, Health, Impetigo, Marketing, PDT, FDA, XL, USPTO, Pharmaceutical industry, Medical imaging

This patented illumination protocol demonstrates Biofronteras commitment to the patients need for innovative treatments.

Key Points: 
  • This patented illumination protocol demonstrates Biofronteras commitment to the patients need for innovative treatments.
  • The patent application claims a method for photodynamic therapy in which a dynamic and innovative illumination protocol is implemented.
  • This protocol consists of changing illumination intensities combined in a predefined order with interruptions of the illumination to specifically modulate and reduce pain perception to the patient.
  • Implementation of the protocol to Biofronteras medical devices requires a software installation and can be rolled-out to both the BF-RhodoLED and BF-RhodoLED XL lamps.

Bridgeline Draws Successful Hand for Top-Tier Trading Card Company

Retrieved on: 
Thursday, December 2, 2021
Catalog, SKU, GLOBE, Environment, NASDAQ, Global Sports Communication, Online shopping

WOBURN, Mass., Dec. 02, 2021 (GLOBE NEWSWIRE) -- Bridgeline Digital, Inc. (NASDAQ: BLIN), a cloud-based marketing technology software provider, announced today that their Hawksearch product has been chosen by a major trading card company to support their online search experience.

Key Points: 
  • WOBURN, Mass., Dec. 02, 2021 (GLOBE NEWSWIRE) -- Bridgeline Digital, Inc. (NASDAQ: BLIN), a cloud-based marketing technology software provider, announced today that their Hawksearch product has been chosen by a major trading card company to support their online search experience.
  • Analysts report that the Global Sports Trading Card Market was valued at $14 Billion and is projected to reach $100 Billion by 2027.
  • This deal, a third leading trading card win for Bridgeline, is quickly positioning Bridgelines site search product as the go-to for trading card search software.
  • The trading card and tabletop brand will use Hawksearchs expansive AI abilities to support their catalog of over 40,000 items.

Yield10 Bioscience Chief Science Officer Dr. Kristi Snell to Present on Advances in Utilizing CRISPR Genome Editing to Increase Seed Oil Content in Camelina at Canola Week Conference

Retrieved on: 
Thursday, December 2, 2021
Security (finance), Energy Independence and Security Act of 2007, Conference, Genome, Proteomics, Company, Gene, U.S. Securities and Exchange Commission, Brassica, Agriculture, Goal, EST, CRISPR, Securities Exchange Act of 1934, Nasdaq, Twitter, Research, GLOBE, GRAIN, CST, PHA, LinkedIn, Facebook, Growth, Securities Act of 1933

Her presentation, entitled Genome editing to increase seed oil in Camelina, will describe the use of CRISPR genome editing to increase seed oil content in Camelina as well as the use of the GRAIN platform to identify novel editing targets for oilseed crops.

Key Points: 
  • Her presentation, entitled Genome editing to increase seed oil in Camelina, will describe the use of CRISPR genome editing to increase seed oil content in Camelina as well as the use of the GRAIN platform to identify novel editing targets for oilseed crops.
  • Yield10 researchers have identified and are currently developing novel traits to increase seed oil content in oilseed crops.
  • Line E3902 was produced using CRISPR genome editing to modify three genes in Camelina involved in oil biosynthesis and oil turnover.
  • Overexpression of C3020 in Camelina produced a ten percent increase in seed oil content in greenhouse studies.